367 related articles for article (PubMed ID: 23212367)
21. Inhibition of TRPC6 channel activity contributes to the antihypertrophic effects of natriuretic peptides-guanylyl cyclase-A signaling in the heart.
Kinoshita H; Kuwahara K; Nishida M; Jian Z; Rong X; Kiyonaka S; Kuwabara Y; Kurose H; Inoue R; Mori Y; Li Y; Nakagawa Y; Usami S; Fujiwara M; Yamada Y; Minami T; Ueshima K; Nakao K
Circ Res; 2010 Jun; 106(12):1849-60. PubMed ID: 20448219
[TBL] [Abstract][Full Text] [Related]
22. TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling.
Kuwahara K; Wang Y; McAnally J; Richardson JA; Bassel-Duby R; Hill JA; Olson EN
J Clin Invest; 2006 Dec; 116(12):3114-26. PubMed ID: 17099778
[TBL] [Abstract][Full Text] [Related]
23. Myocardial TRPC6-mediated Zn
Oda S; Nishiyama K; Furumoto Y; Yamaguchi Y; Nishimura A; Tang X; Kato Y; Numaga-Tomita T; Kaneko T; Mangmool S; Kuroda T; Okubo R; Sanbo M; Hirabayashi M; Sato Y; Nakagawa Y; Kuwahara K; Nagata R; Iribe G; Mori Y; Nishida M
Nat Commun; 2022 Oct; 13(1):6374. PubMed ID: 36289215
[TBL] [Abstract][Full Text] [Related]
24. The proteoglycan syndecan 4 regulates transient receptor potential canonical 6 channels via RhoA/Rho-associated protein kinase signaling.
Liu Y; Echtermeyer F; Thilo F; Theilmeier G; Schmidt A; Schülein R; Jensen BL; Loddenkemper C; Jankowski V; Marcussen N; Gollasch M; Arendshorst WJ; Tepel M
Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):378-85. PubMed ID: 22155451
[TBL] [Abstract][Full Text] [Related]
25. TRPC6 counteracts TRPC3-Nox2 protein complex leading to attenuation of hyperglycemia-induced heart failure in mice.
Oda S; Numaga-Tomita T; Kitajima N; Toyama T; Harada E; Shimauchi T; Nishimura A; Ishikawa T; Kumagai Y; Birnbaumer L; Nishida M
Sci Rep; 2017 Aug; 7(1):7511. PubMed ID: 28790356
[TBL] [Abstract][Full Text] [Related]
26. Transcriptional signatures regulated by TRPC1/C4-mediated Background Ca
Camacho Londoño JE; Kuryshev V; Zorn M; Saar K; Tian Q; Hübner N; Nawroth P; Dietrich A; Birnbaumer L; Lipp P; Dieterich C; Freichel M
Prog Biophys Mol Biol; 2021 Jan; 159():86-104. PubMed ID: 32738354
[TBL] [Abstract][Full Text] [Related]
27. Combined TRPC3 and TRPC6 blockade by selective small-molecule or genetic deletion inhibits pathological cardiac hypertrophy.
Seo K; Rainer PP; Shalkey Hahn V; Lee DI; Jo SH; Andersen A; Liu T; Xu X; Willette RN; Lepore JJ; Marino JP; Birnbaumer L; Schnackenberg CG; Kass DA
Proc Natl Acad Sci U S A; 2014 Jan; 111(4):1551-6. PubMed ID: 24453217
[TBL] [Abstract][Full Text] [Related]
28. TASK-1 and TASK-3 channels modulate pressure overload-induced cardiac remodeling and dysfunction.
Duan W; Hicks J; Makara MA; Ilkayeva O; Abraham DM
Am J Physiol Heart Circ Physiol; 2020 Mar; 318(3):H566-H580. PubMed ID: 31977249
[TBL] [Abstract][Full Text] [Related]
29. Mechanical deformation of ventricular myocytes modulates both TRPC6 and Kir2.3 channels.
Dyachenko V; Husse B; Rueckschloss U; Isenberg G
Cell Calcium; 2009 Jan; 45(1):38-54. PubMed ID: 18635261
[TBL] [Abstract][Full Text] [Related]
30. TRPC3 positively regulates reactive oxygen species driving maladaptive cardiac remodeling.
Kitajima N; Numaga-Tomita T; Watanabe M; Kuroda T; Nishimura A; Miyano K; Yasuda S; Kuwahara K; Sato Y; Ide T; Birnbaumer L; Sumimoto H; Mori Y; Nishida M
Sci Rep; 2016 Nov; 6():37001. PubMed ID: 27833156
[TBL] [Abstract][Full Text] [Related]
31. Dysfunction of the Klotho-miR-30s/TRPC6 axis confers podocyte injury.
Qiu X; Huo J; Xia S; Zhao W; Luo Y; Xia Y
Biochem Biophys Res Commun; 2021 Jun; 557():90-96. PubMed ID: 33862465
[TBL] [Abstract][Full Text] [Related]
32. In Vivo Cardiac-specific Expression of Adenylyl Cyclase 4 Gene Protects against Klotho Deficiency-induced Heart Failure.
Chen K; Wang S; Sun Z
Transl Res; 2022 Jun; 244():101-113. PubMed ID: 35114419
[TBL] [Abstract][Full Text] [Related]
33. Differences in TRPC3 and TRPC6 channels assembly in mesenteric vascular smooth muscle cells in essential hypertension.
Álvarez-Miguel I; Cidad P; Pérez-García MT; López-López JR
J Physiol; 2017 Mar; 595(5):1497-1513. PubMed ID: 27861908
[TBL] [Abstract][Full Text] [Related]
34. Klotho protects the heart from hyperglycemia-induced injury by inactivating ROS and NF-κB-mediated inflammation both in vitro and in vivo.
Guo Y; Zhuang X; Huang Z; Zou J; Yang D; Hu X; Du Z; Wang L; Liao X
Biochim Biophys Acta Mol Basis Dis; 2018 Jan; 1864(1):238-251. PubMed ID: 28982613
[TBL] [Abstract][Full Text] [Related]
35. Different roles of BAG3 in cardiac physiological hypertrophy and pathological remodeling.
Jia P; Wu N; Yang H; Guo Y; Guo X; Sun Y
Transl Res; 2021 Jul; 233():47-61. PubMed ID: 33578031
[TBL] [Abstract][Full Text] [Related]
36. Cyclic GMP/PKG-dependent inhibition of TRPC6 channel activity and expression negatively regulates cardiomyocyte NFAT activation Novel mechanism of cardiac stress modulation by PDE5 inhibition.
Koitabashi N; Aiba T; Hesketh GG; Rowell J; Zhang M; Takimoto E; Tomaselli GF; Kass DA
J Mol Cell Cardiol; 2010 Apr; 48(4):713-24. PubMed ID: 19961855
[TBL] [Abstract][Full Text] [Related]
37. [Regulation of cardiovascular functions by the phosphorylation of TRPC channels].
Nishida M; Saiki S; Kitajima N; Nakaya M; Sato Y; Kurose H
Yakugaku Zasshi; 2010 Nov; 130(11):1427-33. PubMed ID: 21048399
[TBL] [Abstract][Full Text] [Related]
38. TRPC6 and kidney disease: sclerosing more than just glomeruli?
Schlondorff J
Kidney Int; 2017 Apr; 91(4):773-775. PubMed ID: 28314576
[TBL] [Abstract][Full Text] [Related]
39. Prevention of PKG1α oxidation augments cardioprotection in the stressed heart.
Nakamura T; Ranek MJ; Lee DI; Shalkey Hahn V; Kim C; Eaton P; Kass DA
J Clin Invest; 2015 Jun; 125(6):2468-72. PubMed ID: 25938783
[TBL] [Abstract][Full Text] [Related]
40. TRPC channels are necessary mediators of pathologic cardiac hypertrophy.
Wu X; Eder P; Chang B; Molkentin JD
Proc Natl Acad Sci U S A; 2010 Apr; 107(15):7000-5. PubMed ID: 20351294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
